Phase 0 Microdose Study

NCT00975936 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: [14C]-GSK706769
DRUG: Ketoconazole

Sponsor

GlaxoSmithKline